Uterus News and Research

RSS

Estrogen therapy keeps joint pain at bay post hysterectomy

Estrogen therapy can help keep joint pain at bay after menopause for women who have had a hysterectomy. Joint pain was modestly, but significantly, lower in women who took estrogen alone than in women who took placebo in the Women's Health Initiative (WHI) trial.

21 Mar 2013

Scientist awarded $1.2M grant to develop therapy to reduce premature births

A scientist at Case Western Reserve University School of Medicine has been awarded a $1.2 million grant to develop a therapy to reduce the prevalence of premature births, which today affect more than 15 million newborns worldwide each year.

11 Mar 2013

IP chemotherapy increases survival in patients with advanced ovarian cancer

Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy, according to a study that analyzed long-term follow-up from two landmark Gynecologic Oncology Group (GOG) trials comprising 876 patients.

11 Mar 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Study finds major risk factor behind increased risk of adverse outcomes in IVF pregnancies

Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).

26 Feb 2013

Mich. panel strips abortion from Blue Cross bill; Ark. House takes action

A House panel on Thursday overwhelmingly approved legislation to overhaul Blue Cross Blue Shield of Michigan, leaving out anti-abortion provisions that torpedoed an earlier effort to change the status of the state's largest health insurer. The 11-0 votes signaled - at least for now - that one of Republican Gov. Rick Snyder's top legislative priorities could reach his desk without language that led him to veto similar legislation in late December. The Senate OK'd the new Blue Cross bills in late January.

23 Feb 2013

Study finds sharp rise in robotically-assisted hysterectomy use for benign gynecologic disorders

Between 2007 and 2010, the use of robotically-assisted hysterectomy for benign gynecologic disorders increased substantially, although, when compared with laparoscopic hysterectomy, the robotic procedure appears to offer little short-term benefit and is accompanied by significantly greater costs, according to a study appearing in the February 20 issue of JAMA.

20 Feb 2013

Study finds reduced insulin effectiveness, high blood pressure in first-born children

Long a source of sibling rivalry, birth order may raise the risk of first-born children developing diabetes or high blood pressure, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

12 Feb 2013

Long-acting reversible contraception with progestin may increase risk of type 2 diabetes in women

A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.

11 Feb 2013

Roundup: Assisted suicide legalization urged; Abortion bill tensions in Wash., Ore.; Budget squeezes in Ga., Conn.

A push for the legalization of physician-assisted suicide is under way in a half-dozen states where proponents say they see strong support for allowing doctors to prescribe mentally competent, dying individuals with the medications needed to end their own lives. ... Groups such as Compassion & Choices, a national end-of-life advocacy organization, have been working to advance the cause.

10 Feb 2013

Miscarriage and molecular signals: an interview with Prof Brosens and Prof Quenby

Miscarriage is defined as the spontaneous loss of pregnancy before the baby reaches viability. Besides the physical trauma, miscarriage causes considerable anxiety, stress, and depression.

17 Jan 2013

Sexual dysfunction not determined by hysterectomy technique

The prevalence of hypoactive sexual desire disorder after hysterectomy does not vary with the surgical technique used, researchers report.

15 Jan 2013

Overall cancer death rates continue to decline in the U.S.: Report

The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.

9 Jan 2013

Fertility window research uncovers miscarriage mechanism

Research in animals has shed light on how recurrent miscarriage is related to a dysregulation of the monthly “fertility window.”

8 Jan 2013

Molecular signals make some women prone to miscarriage

Scientists have identified molecular signals that control whether embryos are accepted by the womb, and that appear to function abnormally in women who have suffered repeated miscarriages.

3 Jan 2013

Halt Medical receives $15M financing for commercialization of Acessa uterine fibroid treatment system

Halt Medical, Inc. announced today that it has received $15 million of financing to support commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids.

2 Jan 2013

Pelvic exams frequently performed for reasons that are medically unjustified

The pelvic exam, a standard part of a woman's gynecologic checkup, frequently is performed for reasons that are medically unjustified, according to the authors of a UCSF study that may lay the groundwork for future changes to medical practice.

17 Dec 2012

TSEC strategy can benefit postmenopausal women

Investigators at Wake Forest Baptist Medical Center have concluded research on a new postmenopausal hormone therapy that shows promise as an effective treatment for menopausal symptoms and the prevention of osteoporosis without increasing the risk for heart disease or breast cancer.

13 Dec 2012

New method promises to boost stem cell production in laboratory

A new method for generating stem cells from mature cells promises to boost stem cell production in the laboratory, helping to remove a barrier to regenerative medicine therapies that would replace damaged or unhealthy body tissues.

5 Dec 2012

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants

During IVF treatment you will need to take certain drugs. For example, for IVF it will be Follicle Stimulating Hormones (FSH) which are used to stimulate the ovaries to produce a mature egg so that they can be fertilised externally and then put back into the womb.

29 Nov 2012